Scientific Publications

Retinal non-perfusion in diabetic retinopathy
Eye. 2022 Jan; Vol 36, 249-256. doi: 10.1038/s41433-021-01649-0.

Myeloid-resident neuropilin-1 promotes choroidal neovascularization while mitigation inflammation
EMBO Molecular Medicines. 2021 May; Vol 13, Issue 5

Neuropilin-1 expression in adipose tissue macrophages protects against obesity and metabolic syndrome
Science Immunology. 2018 Mar; Vol 3, Issue 21

Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy
Sci Transl Med. 2016 Oct 26; 8(362): 362ra144

Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk
J Clin Invest. 2014 Nov; 124(11): 4807-22. doi: 10.1172/JCI76492.

Neuron-Derived Semaphorin 3A Is an Early Inducer of Vascular Permeability in Diabetic Retinopathy via Neuropilin-1
Cell Metab. 2013 Oct 1; 18(4):505-18. doi: 10.1016/j.cmet.2013.09.003.

Eyeing central neurons in vascular growth and reparative angiogenesis
Blood. 2012 Sep 13; 120(11):2182-94. doi: 10.1182/blood-2012-04-396846. Review.

Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A
Blood. 2011 June 2; 117(22):6024-35. doi: 10.1182/blood-2010-10-311589 Review.

4 Westmount Square, Suite 160
Montreal, Quebec H3Z 2S6
Canada

Business Development: bd@semathera.com
Human Resources: careers@semathera.com
General Inquiries: info@semathera.com

© Copyright 2018-2021 SemaThera Inc.